Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Intimation for To Consider And Approve The Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2023.

 Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2023 ,inter alia, to consider and approve the Audited (Standalone & Consolidated) Financial results of the company for the quarter and financial year ended March 31, 2023.
11-05-2023
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKrishna Institute of Medical Sciences Ltd 2CIN NO.L55101TG1973PLC040558 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 4.17 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Umashankar Mantha Designation: Company Secretary and Compliance Officer EmailId: cs@kimshospitals.com Name of the Chief Financial Officer: Vikas Maheshwari Designation: CFO EmailId: Vikas@kimshospitals.com Date: 25/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
25-04-2023
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015

 Please find enclosed the Certificate under Regulation 40(9) of SEBI (LODR) Regulations 2015, issued by the Practicing Company Secretary for the year ended March 31. 2023.
24-04-2023
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Compliance Certificate For The Period Ended 31St March, 2023

 As per the requirement of Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that all activities in relation to both physical and electronic share transfer facility during the period April 01, 2022 to March 31, 2023 (both days inclusive) are maintained by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Pvt. Ltd a Category-I, Registrar & Share Transfer Agent (RTA), registered with the Securities and Exchange Board of India (SEBI) vide Registration Number: INR000004058..
12-04-2023
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2023.
12-04-2023

Manipal closes in on KIMS Health

 Manipal Hospitals is close to acquiring Kerala-based hospital chain KIMS Health for between INR35bn ($473m) and INR40bn ($541m), backed by Singapore state investor Temasek. The deal will see Manipal buy a stake held by True North, which invested $200m in KIMS Group in 2017. The founders of KIMS are also looking to exit through the deal, according to one of two people cited in the report. Manipal Hospitals has reportedly beaten bids from other strategic and financial investors including Blackstone.
11-04-2023
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Closure of Trading Window

 Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company''s Code of Conduct for Prevention of Insider Trading, we wish to inform you that the trading window of the Company will remain closed (for the purpose of consideration of Audited financial results for the year/quarter ended on 31st March 2023 i.e. from Saturday, 1st April 2023 till 48 hours after the announcement/declaration of the Audited Financial Results.
31-03-2023
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Closure of Trading Window

 Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company''s Code of Conduct for Prevention of Insider Trading, we wish to inform you that the trading window of the Company will remain closed (for the purpose of consideration of Audited financial results for the year/quarter ended on 31st March 2023 i.e. from Saturday, 1st April 2023 till 48 hours after the announcement/declaration of the Audited Financial Results.
31-03-2023
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is having an Investors call with Sundaram Mutual funds on the 21st of March, 2023
21-03-2023

Buy Krishna Institute of Medical Sciences; target of Rs 1660: Prabhudas Lilladher

 Prabhudas Lilladher is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1660 in its research report dated March 20, 2023.
20-03-2023
Next Page
Close

Let's Open Free Demat Account